Actively Recruiting
Using Intestinal Ultrasound to Predict Vedolizumab Response and Healing in Early Crohns Disease A Multicenter Prospective Study
Led by The Third Xiangya Hospital of Central South University · Updated on 2025-07-30
60
Participants Needed
1
Research Sites
13 weeks
Total Duration
AI-Summary
What This Trial Is About
Crohns disease CD is a chronic inflammatory condition of the intestines that can lead to serious complications like obstruction, perforation, abscesses, and fistulas. The exact cause of CD is not fully understood, and its incidence is rising, causing significant social and economic challenges. This study focuses on evaluating the use of intestinal ultrasound to predict the effectiveness of vedolizumab treatment and assess healing of the intestinal wall in patients with early-stage CD. Participants will receive vedolizumab, a humanized antibody that targets specific integrins to reduce gut inflammation. This treatment is given within one month after initial endoscopy and ultrasound assessments. The study emphasizes monitoring changes in bowel wall thickness and other ultrasound markers over about 52 weeks to understand how well vedolizumab works in early CD. No investigational drugs or placebo groups are involved as the study observes patients receiving vedolizumab therapy. During the study, patients will undergo regular intestinal ultrasounds and clinical evaluations to monitor treatment response and intestinal healing. Researchers will focus on bowel wall thickness as the primary outcome over approximately one year. The study also tracks participant safety and treatment adherence. Overall, the study aims to provide evidence to guide personalized treatment plans by using ultrasound to predict and monitor how patients respond to vedolizumab therapy in early Crohns disease.
CONDITIONS
Brief Title
Value of IUS in Predicting Vedolizumab Efficacy and Assessing Transmural Healing in Early Crohn's Disease: A Multicenter, Prospective Study
Research Team
T
Tian Li
Y
Yuwei Wu
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here